@kidneypower.bsky.social
Nephrology and IM 🇲🇽 | #kidneyrunner | 🌱🥗 veggie lover
@kevinyau.bsky.social GLP1 agonist master Jedi presenting at #ERA25.
💉GLP1 agonist reduce ED visits and hospitalizations!!!
📉Awesome methods. Best of the session:
💊DDP4 for comparison, IPTW, ICES data. Ticking all the right boxes (EPI nerd).
💊Only 40% on SGLT2i!!! We should flozinate more!!!
Ahí está el @kevinyau.bsky.social !!!
Muchas felicidades !!!
Que lástima que ahora no pudimos compartir los 3 algunos tragos
A graph of the least-squares mean ratio of the change from baseline in the urinary albumin-to-creatinine ratio in the full analysis population.
In the CONFIDENCE trial in persons with chronic kidney disease and type 2 diabetes, combination therapy with finerenone and empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio than either drug alone. Full trial results: nej.md/4jEVbbk
#ERA25 #MedSky #Nephrology
New Things We Do For No Reason in JHM: Avoiding IV Contrast in Patients with AKI or CKD.
I am squarely in the "contrast-associated AKI is not real" camp. #NephSky #medsky
#Nephpearls #NephSky
17.04.2025 22:58 — 👍 16 🔁 1 💬 0 📌 0
🚨Hey #NephSky!
Welcome to a new #Medsky #Skytorial brought to you by @kireports.bsky.social
Our author is @brianrifkin.bsky.social nephrologist in Hattiesburg, MS
Please check out #KIReportsCommunity educational #blogposts too!
⚠️ The FDA has approved oral iptacopan to treat proteinuria in adults with C3 glomerulopathy. This is the first FDA-approved treatment for C3G. #fda #c3glomerulopathy #c3g #kidneydisease #nephrology #nephsky
24.03.2025 14:31 — 👍 5 🔁 4 💬 0 📌 0Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review 👩🔬🥼🧪👨🔬 #CardioSky #NephSky #cardiovascular #cardio-renal #metabolicdisorder #KidneyResearch #kidneydisease 👇👇👇
www.ahajournals.org/doi/epub/10....
Among those w/ nonproteinuric CKD, use of RASi is associated w/ fewer CV events & lower mortality risk vs. other antihypertensive meds
#Nephpearls #NephSky
📌 Patients w/ nonproteinuric CKD may benefit from “prioritizing RASI for hypertension management”
👉🏼 pubmed.ncbi.nlm.nih.gov/39087321/
In 10 years, the prevalence of T2DM increased in younger (7.8% vs. 4.5%, p < 0.0001) and older individuals (34% vs. 28.4%, p < 0.0001).
In 10 yrs, incidence of T2DM increased by 120% & 150% in the younger & older individuals, respectively.
pmc.ncbi.nlm.nih.gov/articles/PMC...
@isn-india.bsky.social
Title slide
Screening rates for breast cancer (75%) contrasted with PA (2%)
Last up is @bhallaresearch.bsky.social on PA
Appalling screening rates despite similar mortality to breast cancer
#ISNWCN #NephSKy
Honored to have been elected as @theisn.org Regional Board Deputy Chair for North America and the Caribbean 2025-27
#ISNWCN 🇮🇳 #WCN25 🇮🇳 #NephSky
Interesting list
10 things nephrologists hope every PCP/Hospitalist knew from @kdjhaveri.bsky.social
www.nephronpower.com/2025/01/top-...
What else would you add?
#NephSky
@nephjc.bsky.social
Check out the lovely VA for tonight’s discussion from Madiha Aziz. #NephJC
Excited to join BlueSky! Looking forward to connecting and sharing insights here. Let’s make this space meaningful. Any recommendations on who to follow? #Kidneys #Kidneysrock
13.11.2024 01:35 — 👍 5 🔁 0 💬 1 📌 0
New Blood Pressure Target For Individuals at High Risk
#hypertension
#CardioSky
#MedSky
www.acc.org/Latest-in-Ca...
